| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
*University of Pittsburgh Medical Center and
The Western Pennsylvania Hospital, Pittsburgh, Pennsylvania,
Thomas Hospital, Fairhope, Alabama,
Memorial City Hospital, Houston, Texas, and the
||Mary Birch Hospital for Women, San Diego, California
Address correspondence and reprint requests to Jacques E. Chelly, MD, PhD, MBA, Professor of Anesthesiology and Orthopedic Surgery, and Vice Chairman of Clinical Research, Director of Orthopedic Anesthesia and Acute Pain Services Department of Anesthesiology, Pittsburgh School of Medicine, A-1305 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261. Address email to chelje{at}anes.upmc.edu
A noninvasive method of delivery of parenteral opioids for management of acute pain may offer logistic advantages for patients and nursing staff. A patient-controlled transdermal system (PCTS) under development consists of a preprogrammed, self-contained drug-delivery system that uses electrotransport technology (E-TRANS®, ALZA Corp, Mountain View, CA) to deliver 40 µg of fentanyl HCl over 10 min per on-demand dose for patient-controlled analgesia (PCA). In this randomized, double-blinded, placebo-controlled trial we compared the efficacy and safety of on-demand fentanyl HCl PCTS 40 µg against placebo for postoperative pain up to 24 h after major abdominal, orthopedic, or thoracic surgery in 205 patients. The primary efficacy measurement was the percentage of patients withdrawn from the study because of inadequate analgesia after completing at least 3 h of treatment. Secondary efficacy measures included mean pain intensity (using visual analog scales), patient global assessments, and investigator global assessments. Of 189 patients considered evaluable for efficacy, 25% of patients in the fentanyl HCl PCTS 40 µg group withdrew because of inadequate analgesia, compared with 40.4% of the placebo group (P < 0.05). Use of fentanyl HCl PCTS 40 µg was associated with lower VAS scores and higher mean patient and investigator global assessment scores compared with placebo. No patient experienced clinically relevant respiratory depression. This study showed that a fentanyl HCl PCTS 40 µg for PCA was superior to placebo and well tolerated for the control of moderate to severe postoperative pain for up to 24 h after major surgery.
IMPLICATIONS: This multicenter, randomized, double-blinded, placebo-controlled trial showed that an on-demand fentanyl HCl patient-controlled transdermal system (PCTS) was superior to placebo and well tolerated for the control of moderate to severe postoperative pain for up to 24 h after major surgery. This fentanyl HCl PCTS is a preprogrammed, needle free, self-contained drug-delivery system that uses electrotransport technology (iontophoresis) to deliver 40 µg of fentanyl per on-demand dose.
This article has been cited by other articles:
|
|
 |
|
  E. R. Viscusi, M. Siccardi, C. V. Damaraju, D. J. Hewitt, and P. Kershaw The Safety and Efficacy of Fentanyl Iontophoretic Transdermal System Compared with Morphine Intravenous Patient-Controlled Analgesia for Postoperative Pain Management: An Analysis of Pooled Data from Three Randomized, Active-Controlled Clinical Studies Anesth. Analg., November 1, 2007; 105(5): 1428 - 1436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Panchal, C. V. Damaraju, W. W. Nelson, D. J. Hewitt, and J. R. Schein System-Related Events and Analgesic Gaps During Postoperative Pain Management with the Fentanyl Iontophoretic Transdermal System and Morphine Intravenous Patient-Controlled Analgesia Anesth. Analg., November 1, 2007; 105(5): 1437 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Margetts and R. Sawyer Transdermal drug delivery: principles and opioid therapy CEACCP, October 1, 2007; 7(5): 171 - 176. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Grond, J. Hall, A. Spacek, M. Hoppenbrouwers, U. Richarz, and F. Bonnet Iontophoretic transdermal system using fentanyl compared with patient-controlled intravenous analgesia using morphine for postoperative pain management Br. J. Anaesth., June 1, 2007; 98(6): 806 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Power Fentanyl HCl iontophoretic transdermal system (ITS): clinical application of iontophoretic technology in the management of acute postoperative pain Br. J. Anaesth., January 1, 2007; 98(1): 4 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mayes and M. Ferrone Fentanyl HCl Patient-Controlled Iontophoretic Transdermal System for the Management of Acute Postoperative Pain Ann. Pharmacother., December 1, 2006; 40(12): 2178 - 2186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Viscusi, L. Reynolds, S. Tait, T. Melson, and L. E. Atkinson An Iontophoretic Fentanyl Patient-Activated Analgesic Delivery System for Postoperative Pain: A Double-Blind, Placebo-Controlled Trial Anesth. Analg., January 1, 2006; 102(1): 188 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Grass Patient-Controlled Analgesia Anesth. Analg., November 1, 2005; 101(5S_Suppl): S44 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. S. Koo Postoperative pain management with a patient-controlled transdermal delivery system for fentanyl Am. J. Health Syst. Pharm., June 1, 2005; 62(11): 1171 - 1176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. E. Marcus, M. Van Kleef, E. A. J. Joosten, and J. E. Chelly The Quest for New Devices to Improve Postoperative Pain Control * Response Anesth. Analg., August 1, 2004; 99(2): 623 - 624. [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Viscusi, L. Reynolds, F. Chung, L. E. Atkinson, and S. Khanna Patient-Controlled Transdermal Fentanyl Hydrochloride vs Intravenous Morphine Pump for Postoperative Pain: A Randomized Controlled Trial JAMA, March 17, 2004; 291(11): 1333 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
